TY - JOUR
T1 - Characteristics of patients with autosomal polycystic kidney disease reaching kidney failure by age 40
AU - Wigerinck, Stijn
AU - Schellekens, Pieter
AU - Smith, Byron H.
AU - Hanna, Christian
AU - Dachy, Angelique
AU - Chedid, Maroun
AU - Borghol, Abdul Hamid
AU - Senum, Sarah R.
AU - Bockenhauer, Detlef
AU - Harris, Peter C.
AU - Jouret, Francois
AU - Bammens, Bert
AU - Chebib, Fouad T.
AU - Mekahli, Djalila
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to International Pediatric Nephrology Association 2025.
PY - 2025/6
Y1 - 2025/6
N2 - Background: Autosomal dominant polycystic kidney disease (ADPKD) demonstrates broad genetic and phenotypic variability, with kidney failure (KF) occurring across a wide age spectrum. Despite several predictor tools, there remains a need to identify factors associated with rapid disease progression. This study describes the phenotypic characteristics of a multicentric cohort experiencing early-onset KF by age 40. Methods: This retrospective, multicenter cohort study analyzed longitudinal data of rapidly progressive ADPKD patients (n = 199). The prevalence of established risk factors was compared to nine existing ADPKD cohorts (ntotal = 6782) with KF after 40 years of age. We examined the longitudinal impact of early hypertension and urological events on the risk of developing KF. Results: The median age at ADPKD diagnosis was 22.3 years (IQR, 16.5–28.6) and median age of KF was 35.6 years (31.7–38.0). Hypertension was observed in 68.1% of cases, with early-onset hypertension being more common among those with accelerated progression towards KF. Urological events were present in 60.1% of cases, with a high burden of gross hematuria (30.4%). Existing ADPKD cohorts had a mean age of 45.5 years, with weighted prevalences of hypertension (71.1%), kidney stones (22.4%), hematuria (22.9%), and urinary tract infections (22.8%). Extrarenal manifestations were less prevalent compared to other ADPKD cohorts. Conclusion: This study outlines a cohort of ADPKD patients with accelerated disease progression, reaching KF before age 40. Hypertension and urological events were highly prevalent at a young age, emphasizing the importance of early and regular blood pressure monitoring.
AB - Background: Autosomal dominant polycystic kidney disease (ADPKD) demonstrates broad genetic and phenotypic variability, with kidney failure (KF) occurring across a wide age spectrum. Despite several predictor tools, there remains a need to identify factors associated with rapid disease progression. This study describes the phenotypic characteristics of a multicentric cohort experiencing early-onset KF by age 40. Methods: This retrospective, multicenter cohort study analyzed longitudinal data of rapidly progressive ADPKD patients (n = 199). The prevalence of established risk factors was compared to nine existing ADPKD cohorts (ntotal = 6782) with KF after 40 years of age. We examined the longitudinal impact of early hypertension and urological events on the risk of developing KF. Results: The median age at ADPKD diagnosis was 22.3 years (IQR, 16.5–28.6) and median age of KF was 35.6 years (31.7–38.0). Hypertension was observed in 68.1% of cases, with early-onset hypertension being more common among those with accelerated progression towards KF. Urological events were present in 60.1% of cases, with a high burden of gross hematuria (30.4%). Existing ADPKD cohorts had a mean age of 45.5 years, with weighted prevalences of hypertension (71.1%), kidney stones (22.4%), hematuria (22.9%), and urinary tract infections (22.8%). Extrarenal manifestations were less prevalent compared to other ADPKD cohorts. Conclusion: This study outlines a cohort of ADPKD patients with accelerated disease progression, reaching KF before age 40. Hypertension and urological events were highly prevalent at a young age, emphasizing the importance of early and regular blood pressure monitoring.
KW - ADPKD
KW - Autosomal polycystic kidney disease
KW - Early onset kidney failure
KW - Hypertension
KW - Rapid progression clinical biomarkers
UR - http://www.scopus.com/inward/record.url?scp=85217159161&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85217159161&partnerID=8YFLogxK
U2 - 10.1007/s00467-024-06652-7
DO - 10.1007/s00467-024-06652-7
M3 - Article
AN - SCOPUS:85217159161
SN - 0931-041X
VL - 40
SP - 1997
EP - 2007
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 6
ER -